blog

AI Shows Promise in the Clinical Space for Enrollment and Adherence

By BBK Worldwide on Tue, Jun 4, 2019 | 1 min read

While most large pharma companies seem “very open” to new technologies, a recent FiercePharma article also notes that the life science industry hasn’t exactly won accolades for its speed in adopting new artificial intelligence and machine learning technologies. However, since patient lives are at stake, the industry has good reason to proceed with caution.*

Dena Raffa, Director, Account Operations and BBK’s expert in digital innovation, shares her view on the complex topic of AI and machine learning technologies in life sciences. 

Topics: Disruptive Innovation, Trends, AI, Pharma15 Live!, Vlog

Small to Mid-Size Pharmaceutical Companies Are Meeting the Needs of a Shifting Marketplace

By Joan F. Bachenheimer on Tue, Jun 4, 2019 | 2 min read

Last year, smaller companies led in new drug approvals, according to a recent OutsourcingPharma.com article featuring Ken Getz, director of sponsored research at Tufts University. Notably, nearly half of these new drugs were for the treatment of rare diseases, demonstrating a shift within the industry away from a focus on scaling infrastructure.*

Scaling-down-Clinical-research-shifts-its-focus_wrbm_large

CEO and Founding Principal of BBK Worldwide, Joan F. Bachenheimer, responds to the article, explaining that “the precision aspects of clinical trial discovery have remapped the patient experience. The more targeted the investigational therapy, the more individualized the orientation becomes toward patient recruitment and engagement. It’s logical that the search for patients with specific biomarkers begets an orientation centered on individual needs versus a mass orientation."

Topics: Trends, Clinical Research, Rare Disease Research, Patient Experience, Precision Medicine

New eBook: Why and How Emerging Biopharmaceutical Companies Can Do More with Less

By Aaron Fleishman on Tue, Jan 15, 2019 | 1 min read

Ensuring Successful Enrollment of Your Clinical Trials

The market has never been more competitive for small- and mid-size biopharmaceutical companies. While your company may not have the resources or depth of experience as the larger companies, with the right strategies you can find yourself better positioned to deliver results faster and with less expense to reach your clinical trial enrollment goals.

In this free, downloadable ebook, we offer solutions 

Topics: BBK Worldwide, Patient Retention, Patient Recruitment, Patient Engagement, eBook, Technology, Trends, Global Patient Recruitment

The Impact a Travel Program Can Have on Your Patient Recruitment and Engagement Success

By BBK Worldwide on Mon, Jan 7, 2019 | 2 min read

When it comes to the benefits travel programs offer in support of clinical trials, opinions are varied. In a recent article published in International Clinical Trials, BBK’s Hannu Koski and Rob Laurens present compelling data with industry insights. “Talking Travel” looks at the appeal travel assistance programs have from the patients’ perspective.

Topics: Patient Retention, Patient Recruitment, Trends, Patient Travel, Patient Experience, Patient Data, Travel Programs

Innovation in Japan Predicts Big Changes in Medicine

By Minori Shimizu on Tue, Jul 7, 2015 | 3 min read

In June of 2014, Japan’s prime minister, Shinzo Abe said he wanted to increase the market for robots in Japan to $22 billion by 2020 and launched a “robot revolution realization council” to create a five-year blueprint to push the industry forward. On the heels of this announcement the New Energy and Industrial Technology Development Organization (NEDO) has recruited Kawasaki and Panasonic to create a robot to perform more intricate tasks, including brain surgery. Their goal is to have products in clinical trials as soon as 2019. This increase in robotic advancement is expected to minimize error and maximize efficiency and precision during medical procedures. In addition, the use of robots to complete jobs usually done by humans has the potential to decrease overall costs in the coming years.

Topics: Technology, Trends

Google X Searches for What it Means to be Healthy

By Matt Kibby on Tue, Aug 26, 2014 | 3 min read

Prevention vs. Treatment
Google’s semi-secret and futuristic research lab, Google X, is busy working on something new – the Baseline Study. The idea is to define what it means to be “healthy” so that one day, this health baseline might help us better detect certain health risks and identify changes relating to serious, more debilitating diseases before they worsen. 

Topics: mHealth, Trends

Update From Japan: Clinical Trial Recruitment

By Aoyagi Kiyoshi on Mon, Jul 29, 2013 | 2 min read

A few months ago, my colleague Sean Ambo and I flew in from Tokyo. We work with CROèe, BBK’s Patient Recruitment Global Alliance partner supporting enrollment efforts in Japan. We'll be here for more than a year as part of our initiative to collaborate with BBK. I've been to Boston a number of times, and this is Sean's second trip here.

In the meantime, we've been integrating our experiences and sharing our expertise on patient recruitment in Japan with our American counterparts at BBK. They recently asked us to share some insights in a blog. So as you would say in the States, "Here goes."

Topics: Trends

Don’t Google It

By Joan F. Bachenheimer on Wed, May 22, 2013 | 4 min read

You are diagnosed with a disease. You are scared. Your doctor has more information than you do but, you are the one who has to agree or disagree to proposed treatments. You think you have the power of the Internet within reach. When you get home you will search and read. Within the same moment that you devise your web-based plan, the doctor – who, disturbingly, you have met for the first time at this appointment – says to you, in an emphatic fashion, “Don’t Google it.”

Topics: Trends

Part 1: Maximizing Positive Trends in Global Patient Recruitment

By Rob Laurens on Fri, Apr 26, 2013 | 2 min read

Today’s trends in global patient recruitment are creating the opportunity for greater momentum than ever before. However, it’s important to strategically use only the campaign tactics that bring the greatest value based on site capabilities and the unique study at hand. In part one of Rob’s two-part blog series, he considers today’s positive trends. Look for part two of this series next week where Rob will discuss how best to maximize these trends.

Topics: Patient Recruitment, Patient Advocacy, Social Media, Technology, Trends

Mystery Meat

By Joan F. Bachenheimer on Thu, May 17, 2012 | 3 min read

So, you go to a restaurant and you order steak. What comes to the table doesn’t remotely resemble the savory course you envisioned. In fact, you can’t even tell exactly what sort of carnivore was slain for your dinner. Do you eat it? Not usually? Without a good sense of what you are getting into, you are less likely to take an action.

Topics: Trends

 
Subscribe To Our Blog